Fairfield Financial Advisors, LTD 23and Me Holding Co. Transaction History

Fairfield Financial Advisors, LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Oct 07, 2024	SELL	$2.06 - $3.47 $2,523 - $4,250	-1,225 Closed	0 $0
Q3 2022 Oct 07, 2024	BUY	$2.6 - $5.12 $3,185 - $6,272	1,225 New	1,225 $3.5 Million
Q2 2022 Oct 07, 2024	BUY	$2.19 - $3.98 $2,682 - $4,875	1,225 New	1,225 $3.04 Million
Q1 2022 Oct 07, 2024	BUY	$3.28 - $7.12 $4,017 - $8,722	1,225 New	1,225 $4.69 Million

116

82.5M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $823M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Fairfield Financial Advisors, LTD, based on Form 13F filings with the SEC.

Stay updated on Fairfield Financial Advisors, LTD with notifications on news.